bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析

◆英語タイトル:bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C8763
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

bluebird bio Inc (BLUE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti D for the treatment of cerebral adrenoleukodystrophy (CALD); LentiGlobin for the treatment of transfusion-dependent beta thalassemia and sickle cell disease, besides compounds under development for the treatment of various cancers. The company has collaboration with various pharmaceutical companies to discover, develop and commercialize gene therapy products to treat cancer. bluebird bio is headquartered in Cambridge, Massachusetts, the US.

bluebird bio Inc Key Recent Developments

Oct 05,2018: bluebird bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin™ Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia
Oct 05,2018: bluebird bio Announces European Medicines Agency s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent -Thalassemia
Oct 01,2018: bluebird bio to Present at the LEERINK Partners Roundtable Series Rare Disease Immuno-Oncology
Aug 24,2018: Bluebird Bio and Gritstone Oncology partner on cancer cell therapies
Aug 08,2018: Bluebird Bio and Regeneron to collaborate on cancer cell therapies

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
bluebird bio Inc – Key Facts 6
bluebird bio Inc – Key Employees 7
bluebird bio Inc – Key Employee Biographies 8
bluebird bio Inc – Major Products and Services 10
bluebird bio Inc – History 11
bluebird bio Inc – Company Statement 13
bluebird bio Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
bluebird bio Inc – Business Description 16
bluebird bio Inc – Corporate Strategy 17
bluebird bio Inc – SWOT Analysis 18
SWOT Analysis – Overview 18
bluebird bio Inc – Strengths 18
bluebird bio Inc – Weaknesses 19
bluebird bio Inc – Opportunities 20
bluebird bio Inc – Threats 21
bluebird bio Inc – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
bluebird bio Inc, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Oct 05, 2018: bluebird bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin™ Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia 32
Oct 05, 2018: bluebird bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin™ Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia 33
Oct 05, 2018: bluebird bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin™ Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia 34
Oct 05, 2018: bluebird bio Announces European Medicines Agency s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent -Thalassemia 35
Oct 05, 2018: bluebird bio Announces European Medicines Agency s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent -Thalassemia 36
Oct 05, 2018: bluebird bio Announces European Medicines Agency s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent -Thalassemia 37
Aug 24, 2018: Bluebird Bio and Gritstone Oncology partner on cancer cell therapies 38
Aug 24, 2018: Bluebird Bio and Gritstone Oncology partner on cancer cell therapies 39
Aug 08, 2018: Bluebird Bio and Regeneron to collaborate on cancer cell therapies 40
Aug 08, 2018: Bluebird Bio and Regeneron to collaborate on cancer cell therapies 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
bluebird bio Inc, Key Facts 6
bluebird bio Inc, Key Employees 7
bluebird bio Inc, Key Employee Biographies 8
bluebird bio Inc, Major Products and Services 10
bluebird bio Inc, History 11
bluebird bio Inc, Other Locations 14
bluebird bio Inc, Subsidiaries 14
bluebird bio Inc, Key Competitors 22
bluebird bio Inc, Ratios based on current share price 23
bluebird bio Inc, Annual Ratios 24
bluebird bio Inc, Annual Ratios (Cont...1) 25
bluebird bio Inc, Interim Ratios 27
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
bluebird bio Inc, Recent Deals Summary 31
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

List of Figures
bluebird bio Inc, Performance Chart (2013 - 2017) 26
bluebird bio Inc, Ratio Charts 28
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
bluebird bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Commonwealth Scientific and Industrial Research Organisation:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業財務及び戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals) is a pharmaceutical company that develops next-generation synthetic cannabinoid therapeutics. The company’s products comprise pro-drug of THC transdermal patch and permeation-enhanced gel. The company provides transdermal delivery for pat …
  • Atlantic Pro-Nutrients Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atlantic Pro-Nutrients Inc (APN) is a health science company that manufactures dietary supplements and functional foods. The company offers products in the areas of women's health, men's health, sports nutrition, immune health, cytokine balance support, adrenal support, antioxidants, bone he …
  • Nutritional Holdings Limited (NUT):企業の財務及び戦略的SWOT分析
    Summary Nutritional Holdings Limited (Nutritional Holdings) is a pharmaceutical company that offers nutritional supplements. The company manufactures and markets fortified dry food products. It conducts business under two divisions, namely, nutritional food and Impilo’s Drugs. Nutritional Holdings’ …
  • Sensorion SA (ALSEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • Golden Meditech Holdings Limited (801):企業のM&A・提携動向(医療機器分野)
    Summary Golden Meditech Holdings Limited (Golden Meditech) is an integrated healthcare service provider that provides health care services and develops, manufactures and distributes blood-related medical devices. The company offers autologous blood recovery system. It provides healthcare services su …
  • KKR Financial Holdings LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' KKR Financial Holdings LLC Merg …
  • Immatics Biotechnologies GmbH:企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Public Service Enterprise Group Inc. (PEG):企業の財務及び戦略的SWOT分析
    Public Service Enterprise Group Inc. (PEG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • IVP Limited (IVP):企業財務及び戦略的SWOT分析
    Summary IVP Limited (IVP) is a chemical company that manufactures and exports chemicals, castings and allied products. The company's products comprise phenol base resins, alkyd base resins, special binders for refractories, water based coatings, alcohol based coatings, inoculants for cast iron indus …
  • Convergex Group, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Convergex Group, LLC Mergers an …
  • Bristol-Myers Squibb Co (BMY):医療機器:M&Aディール及び事業提携情報
    Summary Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and virolo …
  • Omega Pharma NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold product …
  • Hubei Biocause Pharmaceutical Co., Ltd. (000627):企業の財務及び戦略的SWOT分析
    Summary Hubei Biocause Pharmaceutical Co., Ltd. (Hubei Biocause) is a chemical company that provides pharmaceutical, chemical and new energy fuels. The company offers products which include API’s and intermediates; chemicals and formulations. Its formulations comprise gatifloxacin, ibuprofen and pse …
  • Continental AGの企業概要及び財務/SWOT分析
    Continental AG Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Continental AG annual and quarterly forecasts made by stock market experts. The report also enables direct comp …
  • Hilton Worldwide Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hilton Worldwide Holdings, Inc. …
  • CaixaBank SA:戦略・SWOT・企業財務分析
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sorrento Therapeutics Inc (SRNE):企業のM&A・提携動向(医療分野)
    Summary Sorrento Therapeutics Inc (STI), formerly QuikByte Software, Inc., which develops novel treatments for cancer, inflammation and autoimmune diseases. It discovers small molecules, antibody drug conjugates, and antibodies for the treatment of cancer and its associated pain. Its pipeline produc …
  • TCG Lifesciences Ltd:企業のM&A・提携動向(医療分野)
    Summary TCG Lifesciences Ltd (TCG Lifesciences), formerly Chembiotek Research International Private Limited is a subsidiary of TCG Digital Solutions LLC, contract research service provider that offers research services in the areas of drug discovery and drug development to pharma and biotechnology c …
  • Social Solutions, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Social Solutions, Inc. Mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆